Skip to main content

Advertisement

SpringerLink
Log in

Erectile-dysfunction therapies

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

Key Points

Disclaimer: see online

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Prevalence of erectile dysfunction (ED).
Figure 2: Market for PDE5 inhibitors, 2001–2006E.

References

  1. Wood, A. J. Drug therapy: erectile dysfunction. N. Engl. J. Med. 342, 1802–1813 (2000).

    Article  Google Scholar 

  2. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. & McKinlay, J. B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151, 54–61 (1994).

    Article  CAS  PubMed  Google Scholar 

  3. Sorbera, L. A. et al. Vardenafil. Drugs Future 26, 141–144 (2001).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. biotechnology analysts at Bear Stearns & Co., 383 Madison Avenue, New York, 10179, New York, USA

    Ronald C. Renaud & Hayley Xuereb

Authors
  1. Ronald C. Renaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hayley Xuereb
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

DATABASES

LocusLink

PDE1

PDE2

PDE3

PDE4

PDE5

PDE6

PDE7

PDE8

PDE9

PDE10

Medscape DrugInfo

dopamine

intracavernous alprostadil

isosorbide dinitrate

isosorbide mononitrate

nitroglycerin

papaverine

phentolamine

sildenafil

transurethral alprostadil

trazodone

yohimbine hydrochloride

Rights and permissions

Reprints and permissions

About this article

Cite this article

Renaud, R., Xuereb, H. Erectile-dysfunction therapies. Nat Rev Drug Discov 1, 663–664 (2002). https://doi.org/10.1038/nrd898

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd898

  • Springer Nature Limited

This article is cited by

Search

Navigation